These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19788359)

  • 1. Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.
    Shah SS; Hall M; Srivastava R; Subramony A; Levin JE
    Clin Infect Dis; 2009 Nov; 49(9):1369-76. PubMed ID: 19788359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest.
    Valiquette L; Low DE; McGeer AJ
    Clin Infect Dis; 2009 Nov; 49(9):1377-9. PubMed ID: 19788361
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.
    Kaul R; McGeer A; Norrby-Teglund A; Kotb M; Schwartz B; O'Rourke K; Talbot J; Low DE
    Clin Infect Dis; 1999 Apr; 28(4):800-7. PubMed ID: 10825042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score-Matched Analysis From 130 US Hospitals.
    Kadri SS; Swihart BJ; Bonne SL; Hohmann SF; Hennessy LV; Louras P; Evans HL; Rhee C; Suffredini AF; Hooper DC; Follmann DA; Bulger EM; Danner RL
    Clin Infect Dis; 2017 Apr; 64(7):877-885. PubMed ID: 28034881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic shock syndrome surveillance in UK children.
    Adalat S; Dawson T; Hackett SJ; Clark JE;
    Arch Dis Child; 2014 Dec; 99(12):1078-82. PubMed ID: 24790135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous immunoglobulin on the outcome of children with septic shock in a PICU: a retrospective cohort study.
    Huang H; Chen J; Dang H; Liu C; Huo J; Fu YQ
    Eur J Pediatr; 2023 Dec; 182(12):5315-5323. PubMed ID: 37733114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
    Parks T; Wilson C; Curtis N; Norrby-Teglund A; Sriskandan S
    Clin Infect Dis; 2018 Oct; 67(9):1434-1436. PubMed ID: 29788397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of intravenous immunoglobulin therapy for invasive group A Streptococcus infection: A Japanese nationwide observational study.
    Senda A; Endo A; Fushimi K; Otomo Y
    Int J Infect Dis; 2023 Oct; 135():84-90. PubMed ID: 37586661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of intravenous immune globulin in streptococcal toxic shock syndrome and Clostridium difficile infection.
    Shah PJ; Vakil N; Kabakov A
    Am J Health Syst Pharm; 2015 Jun; 72(12):1013-9. PubMed ID: 26025992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections.
    Carapetis JR; Jacoby P; Carville K; Ang SJ; Curtis N; Andrews R
    Clin Infect Dis; 2014 Aug; 59(3):358-65. PubMed ID: 24785239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human intravenous immunoglobulin for experimental streptococcal toxic shock: bacterial clearance and modulation of inflammation.
    Sriskandan S; Ferguson M; Elliot V; Faulkner L; Cohen J
    J Antimicrob Chemother; 2006 Jul; 58(1):117-24. PubMed ID: 16670109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study.
    Linnér A; Darenberg J; Sjölin J; Henriques-Normark B; Norrby-Teglund A
    Clin Infect Dis; 2014 Sep; 59(6):851-7. PubMed ID: 24928291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxic shock syndrome in children: epidemiology, pathogenesis, and management.
    Chuang YY; Huang YC; Lin TY
    Paediatr Drugs; 2005; 7(1):11-25. PubMed ID: 15777108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010-2017
    Cook A; Janse S; Watson JR; Erdem G
    Emerg Infect Dis; 2020 Jun; 26(6):1077-1083. PubMed ID: 32442091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic shock syndrome in Australian children.
    Chen KY; Cheung M; Burgner DP; Curtis N
    Arch Dis Child; 2016 Aug; 101(8):736-40. PubMed ID: 27117838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Necrotizing Soft Tissue Infections: IVIG.
    Madsen MB; Bergsten H; Norrby-Teglund A
    Adv Exp Med Biol; 2020; 1294():105-125. PubMed ID: 33079366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse venous thromboemboli associated with IVIg therapy in the treatment of streptococcal toxic shock syndrome: case report and review.
    Geller JL; Hackner D
    Ann Hematol; 2005 Sep; 84(9):601-4. PubMed ID: 15815906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Streptococcal Toxic Shock Syndrome Caused by Group G Streptococcus, United Kingdom.
    Baxter M; Morgan M
    Emerg Infect Dis; 2017 Jan; 23(1):127-129. PubMed ID: 27983491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study.
    Tagami T; Matsui H; Fushimi K; Yasunaga H
    Clin Infect Dis; 2015 Aug; 61(3):385-92. PubMed ID: 25882302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin for the treatment of childhood encephalitis.
    Iro MA; Martin NG; Absoud M; Pollard AJ
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD011367. PubMed ID: 28967695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.